Cancers are caused by mutation of cells. Rapid and mass proliferation of mutated cells deprives normal tissues and organs of their functions and eventually causes death. Traces of malignant tumors can be found in all human organs except the hair.
The human body is unable to detect any symptoms when a few hundred cells are cancerous. Only when cancer cells proliferate to form a complete tumor is awareness of symptoms triggered. Thus, it is difficult to detect cancer prior to tumor formation, even with the aid of precision instruments. But do you know that when cancer cells spread, it is almost impossible to predict where cancer will occur next? Thus prevention is definitely a more important strategy than treatment in slowing cancer growth.
Much research on cancer therapy states effective treatment should be given prior to tumor formation, as this is the best time for treating cancers. Once cancer cells spread out and enter the lymph system, it is impossible to predict accurately where cancers will occur next. As such, we strongly emphasize that prevention is a better strategy than treatment in slowing cancer growth.
In 1985, Prof Da-Cheng Dong fed mice with tumor, with ganoderma fruiting body extracts for 30 days. High doses of the extracts were found to be effective in inhibiting tumor growth, but ineffective at low dosage.
In 2004, Prof Zhi-Bin Lin found that ganoderma polysaccharide peptides are able to fight cancer in mice because they indirectly prevent tumor cells from growing new blood vessels, thereby causing cancer cell apoptosis due to starvation.
In 2002, Kimura fed mice implanted with malignant lung cancer cells with high dosage ganoderma triterpenoids for 18 days. It was found that cancer cell metastasis in the spleen and liver of mice in the treated group was significantly less than in the control group. It inhibit cancer by directly arresting the growth of new blood vessels in the cancer cells.
In 2006, Jian-Jiang Zhong from East China University of Science and Technology found ganoderic acid T to be effective in inhibiting tumor growth of mice implanted with lung cancer cells. The higher the dosage, the more effective the cancer cell inhibition.
Successful in-vitro experiments were conducted using triterpenoids on the following types of cancer cells: leukemia cells, hepatoma (liver) cells, nasopharyngeal (throat) carcinoma, lung cancer, prostate cancer.
Ganoderma / Lingzhi and Human Clinical Study
In 1995, Thaithatgom from Thailand used ganoderma fruiting body extracts as auxiliary treatment for 80 cancer patients. Findings:-
- It's effective in extending the lifespan of up to 50% of patients
- Side effects from chemo and radiotherapy were decreased
- Patients showed pain-relief, good appetite and better quality of life
- 41 patients remained alive after 3 months
- Natural killer cell activity of 68.3% patients significantly increased
- Chemo and radiotherapy side-effects eg. extreme fatigue, weight loss, vomiting, cold sweat and diarrhea were reduced, improving their quality of life
According to a professional periodical "Healthy Ganoderma" published in Taiwan, a scientific survey was conducted in 2007 on patients who had been using ganoderma extract as anti-cancer auxiliary treatment for the past 20 years. 70% of over 700 cancer patients interviewed thought that ganoderma extracts could reduce side-effects of chemo and radiotherapy and enhance immunity.
Numerous scientific researches have observed that regardless of the stages of treatment, the most important approach of ganoderma / lingzhi is to:
What Ganoderma / Lingzhi To Choose?
Click here to refer to Shuang Hor company website for Product Description and Price.